Time Tested Since 1971
Cart 0

News

Summer 2017 Update

In this supplement we added new stability information for these existing drug monographs: BUSULFAN, CARBOPLATIN, CISPLATIN, CLADRIBINE, CYTARABINE, DACARBAZINE, DACTINOMYCIN, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, HYDROCORTISONE SODIUM PHOSPHATE, IDARUBICIN HYDROCHLORIDE, IFOSFAMIDE, METHOTREXATE, MITOMYCIN, MITOXANTRONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, PENTOSTATIN, TOPOTECAN HYDROCHLORIDE, VINBLASTINE SULFATE, VINCRISTINE SULFATE, and VINORELBINE TARTRATE. In addition new compatibility information is reported for over 40 existing drug monographs, including entries for PIPERACILLIN AND TAZOBACTAM with VANCOMYCIN HYDROCHLORIDE, ABCIXIMAB with six other drugs, CLONAZEPAM with six other drugs, HALOPERIDOL LACTATE with thirteen other drugs, OMEPRAZOLE HYDROCHLORIDE with five other drugs, and TIROFIBAN HYDROCHLORIDE with seven other drugs.

Read more →


Spring 2017 IV Drug Compatibility Updates

In this supplement we added new drug monographs with stability and compatibility data for these drugs: BLINATUMOMAB, BRIVARACETAM, ERIBULIN MESYLATE, FERRIC CARBOXYMALTOSE, DECITABINE, FOMEPIZOLE, GLOBULIN, IMMUNE (HUMAN) AND HYALURONIDASE, IBANDRONATE SODIUM, IDARUCIZUMAB, ISAVUCONAZONIUM SULFATE, RASBURICASE, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, SODIUM NITRITE, TEMOZOLOMIDE, VINCRISTINE SULFATE LIPOSOME, and ZOLEDRONIC ACID. Also, we added new stability information for these existing drug monographs: AZTREONAM, BACLOFEN, BUSULFAN, CARBOPLATIN, CEFPIROME SULFATE, CEFEPIME HYDROCHLORIDE, CEFTAZIDIME, DORIPENEM, FENTANYL CITRATE, HEPARIN SODIUM, HETASTARCH, KETAMINE HYDROCHLORIDE, LEVETIRACETAM, MEROPENEM, NITROPRUSSIDE SODIUM, PACLITAXEL, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM, TACROLIMUS, TRANEXAMIC ACID, and VANCOMYCIN HYDROCHLORIDE. In addition...

Read more →


Winter 2016 - New & Updated IV Compatibility Information

In this update we added new drug monographs for CEFTAZIDIME AND AVIBACTAM, CEFTOLOZANE AND TAZOBACTAM, and SUGAMMADEX. Also, we added new stability information for these drugs:  AMPICILLIN SODIUM, LABETALOL HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, POLYMYXIN B SULFATE, and PROPAFENONE HYDROCHLORIDE. In addition new compatibility information is reported for ESMOLOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, and METOPROLOL HYDROCHLORIDE, each in combination with 14 different drugs. Overall, new compatibility information is included for over 90 unique drug pairs in this supplement.

Read more →


Fall 2016 IV Compatibility Update

In this supplement we added new drug monographs for DEFIBROTIDE SODIUM, CLEVIIDIPINE, IPILIMUMAB, and POSACONAZOLE. Also, we added new stability information for these drugs: AZACITIDINE, BENDAMUSTINE HYDROCHLORIDE, DEFEROXAMINE MESYLATE, DOXARUBICIN HYDROCHLOIRIDE, ERTAPENEM, GANCICLOVIR SODIUM, and MELPHALAN. In addition new compatibility information is reported for LEVOFLOXACIN, MOXIFLOXACIN, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, TRAMADOL HYDROCHLORIDE, and VANCOMYCIN HYDROCHLORIDE.

Read more →


Summer 2016

In this supplement we added new drug monographs for CANGRELOR (including compatibility information with 99 drugs), and for TEDIZOLID (including compatibility information with 86 drugs). Also, we added new stability information for fifteen drugs: ABCIXIMAB, ALFENTANIL HYDROCHLORIDE, ALTEPLASE, AZITHROMYCIN DIHYCLATE, BUPIVACAINE LIPOSOME, CO-TRIMOXAZOLE, DAPTOMYCIN, DIGOXIN, ERTAPENEM, MICAFUNGIN SODIUM, MILRINONE LACTATE, PROPOFOL, QUINUPRISTIN AND DALFOPRISTIN, ROPIVACAINE HYDROCHLORIDE and ZICONOTIDE. In addition new compatibility information is reported for BUPIVACAINE LIPOSOME AND ZICONOTIDE.

Read more →